日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Using genomic scars to select immunotherapy beneficiaries in advanced non-small cell lung cancer

利用基因组瘢痕筛选晚期非小细胞肺癌免疫治疗的受益者

Donker, H C; van Es, B; Tamminga, M; Lunter, G A; van Kempen, L C L T; Schuuring, E; Hiltermann, T J N; Groen, H J M

Large cell neuroendocrine carcinoma with a solitary brain metastasis and low Ki-67: a unique subtype

伴有孤立性脑转移和低Ki-67表达的大细胞神经内分泌癌:一种独特的亚型

Hermans, B C M; Derks, J L; Groen, H J M; Stigt, J A; van Suylen, R J; Hillen, L M; van den Broek, E C; Speel, E J M; Dingemans, A-M C

Respiratory level tracking with visual biofeedback for consistent breath-hold level with potential application in image-guided interventions

利用视觉生物反馈进行呼吸水平追踪,以实现稳定的屏气水平,并有望应用于图像引导介入治疗。

Heerink, W J; Dorrius, M D; Groen, H J M; Van Ooijen, P M A; Vliegenthart, R; Oudkerk, M

Complication rates of CT-guided transthoracic lung biopsy: meta-analysis

CT引导下经胸肺活检并发症发生率:荟萃分析

Heerink, W J; de Bock, G H; de Jonge, G J; Groen, H J M; Vliegenthart, R; Oudkerk, M

A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC).

一项随机、双盲、II 期研究,评估厄洛替尼联合或不联合舒尼替尼作为转移性非小细胞肺癌 (NSCLC) 二线治疗的疗效

Groen H J M, Socinski M A, Grossi F, Juhasz E, Gridelli C, Baas P, Butts C A, Chmielowska E, Usari T, Selaru P, Harmon C, Williams J A, Gao F, Tye L, Chao R C, Blumenschein G R Jr